JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations

Business by 2FIRSTS
Jun.05.2024
JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations
JSTE Electronics announces self-liquidation after contract dispute, urging creditors to beware of false claims. JFT responds.

Statement:

This announcement is from the official website of JUSTFOG. 2FIRSTS is dedicated to industry research and sharing more industry information. Readers are encouraged to evaluate the information and opinions presented in the article on their own.


 

On the evening of June 3rd, JSTE Electronics Technology (Dongguan) Co., Ltd. announced that its original main foreign client, JFT Co., Ltd., maliciously unilaterally terminated the contract and maliciously delayed payment, resulting in the target company incurring a loss of over 60 million yuan. The target company faced severe difficulties in operation and management, and ultimately decided to proceed with voluntary liquidation. (For more information, see 2FIRSTS report: JSTE Electronics Technology (Dongguan) Co., Ltd. announces voluntary liquidation)

 

On the afternoon of June 5th, JFT Co., Ltd. issued a statement on its official website for the brand "JUSTFOG" in response to the matter. Here is an overview of the main points.

 

  • JustFog Technology (JFT) has accused JSTE Company of defamation and will pursue legal action. 
  • JFT terminates its partnership with JSTE Company after discovering that key personnel, including Mr. Liu and Mr. Ge, had established related companies to inflate prices of raw materials and sell counterfeit products using the "JUSTFOG" registered trademark in violation of fair business practices. 
  • JSTE Company's dissolution is due to their actions of selling counterfeit e-cigarettes with the registered trademark to foreign customers outside of the e-cigarette trading platform after terminating their partnership with JFT, which led to criminal investigation unrelated to JFT. 
  • In order to prevent further losses for JSTE Company's creditors, we would like to inform all creditors that we have not defaulted on any payments to JSTE Company, and advise against falling for any deception tactics.

 

JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations
Official website screenshot | JUSTFOG Official Website

 

JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations

 

JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations

 

The original text is: 

 

A Letter to Creditors of Jiasite Technology (Dongguan) Co., Ltd.

 

Jiaste Technology (Dongguan) Co., Ltd. creditors, our company noticed an article titled "Jiaste Electronic Technology (Dongguan) Co., Ltd. self-liquidation announcement" on e-cigarette public accounts and other online platforms on June 4, 2024 Beijing time. The announcement contained defamatory statements against our company, alleging that "due to the malicious unilateral termination of contracts and malicious withholding of payments by our main foreign client, JFT Corporation, causing the company to incur losses exceeding 60 million yuan, the company has encountered severe operational difficulties." (quote from excerpt of "Jiaste Electronic Technology (Dongguan) Co., Ltd. self-liquidation announcement")

 

The false rumors spread rapidly on the internet after being reposted by some media outlets, causing a negative impact. The actions of Jiaeste Company have constituted defamation, and we will pursue legal action against them. In order to clear our name, we are writing to the creditors of Jiaeste Company as follows:

 

During our cooperation with JSTE Company, we have always upheld the principle of good faith cooperation and fulfilled the relevant provisions in both parties' contract as agreed.

 

Our company has terminated the partnership with JSTE Company due to the discovery that the actual controllers Liu X, Ge X, and other senior executives have privately established related companies to inflate raw material procurement prices and sell counterfeit products with the "JUSTFOG" registered trademark, which has gone against the principles of ethical cooperation and legality.

 

The main reason for the dissolution of JSTEE Company this time is that after we terminated cooperation with them, they resorted to selling counterfeit e-cigarettes with registered trademarks to foreign customers through circumvention of the e-cigarette trading platform, leading to their self-preservation actions in response to criminal investigations, which are unrelated to our company.

 

In order to prevent further losses for the creditors of Jest Company, we would like to inform all creditors that our company does not owe any money or other cooperation funds to Jest Company. Please do not be deceived.

 

Please publish, repost, or circulate any misleading information related to the subject promptly delete all content suspected of infringement, and stop all actions such as forwarding and commenting that may lead to the spread of such misleading information, in order to prevent further harm.

 

Thank you all for your attention and support for our company!!!

 

JFT Corporation

 

June 4, 2024

 

2FIRSTS will continue to monitor and follow up on this event, so stay tuned.

 

Click on the texts or images to read: "Beware of e-cigarette industry debt risks: How does the operational dilemma of a single enterprise affect the entire industry chain?"

 

JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Mesa Underwriters Specialty Insurance Company has asked a federal court in Washington to declare that it has no duty to defend or indemnify vape distributor i5 Distribution in a product liability case involving an Elf Bar BC5000. The plaintiff alleges that the disposable vape caught fire and exploded in his pocket, causing severe burns and ultimately requiring an above-the-knee amputation of his left leg. MUSIC is relying on a tobacco, nicotine or nicotine replacement products exclusion and a premises limitation endorsement. The court has not ruled on the coverage dispute.
News
Sep.10
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24